<DOC>
	<DOCNO>NCT01560078</DOCNO>
	<brief_summary>Tubercular pleural effusion second common form extrapulmonary tuberculosis ( EPTB ) see clinical practice tuberculosis ( TB ) lymphadenitis . It common complete treatment patient tubercular pleural effusion six month short-course chemotherapy Directly Observed Treatment Short-Course ( DOTS ) , pleural effusion resolve completely . In case treatment need extend one two month give extension pouch . Since DOTS recommend demonstration complete resolution tubercular pleural effusion end treatment completion , paucity data term patient declare cure sputum negative pulmonary extra-pulmonary TB include TB pleural effusion well . This project aim look patient characteristic , treatment outcome , compute number case require extended regimen extent pleural effusion persistent end six month standard DOTS therapy .</brief_summary>
	<brief_title>Efficacy Study Thrice Weekly Directly Observed Treatment Short-Course Regimen Tubercular Pleural Effusion</brief_title>
	<detailed_description>India 's Revised National Tuberculosis Control Programme ( RNTCP ) , base Directly Observed Treatment Short-Course ( DOTS ) strategy , begin pilot project 1993 launched national program 1997 . Three category treatment recommend base disease characteristic . Category III regimen comprise thrice-weekly isoniazid , rifampicin pyrazinamide intensive phase ; isoniazid rifampicin continuation phase . This regimen recommend sputum smear negative extrapulmonary tuberculosis ( TB ) patient seriously ill . The omission ethambutol non-cavitary , smear-negative pulmonary TB patient know human immunodeficiency virus ( HIV ) negative endorse World Health Organization ( WHO ) guideline . However , view high level initial resistance isoniazid many area , recent guideline recommend add ethambutol intensive phase , effectively eliminate category III . This study design multicentre , longitudinal observational study carry 2006 2011 . Three hundred sixty patient plan enrol across 4 centre , namely AIIMS ( New Delhi ) , SMS Medical College ( Jaipur ) , SVIMS ( Tirupati ) BJ Medical College ( Ahmedabad ) ; i.e . 90 patient centre . Lost follow-up/default rate 12 % expect study . Recruitment do study sit directly well referral via nearby DOTS centre , hospital chest clinic .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Pleural Effusion</mesh_term>
	<criteria>Patients unilateral TB pleural effusion &lt; 1500 ml Patients &lt; 15 year &gt; 65 year exclude Patients opacity great four intercostal space posteroanterior ( PA ) chest radiograph Bilateral pleural effusion Patients failures/defaulters/relapses ( eligible cat II per RNTCP guideline ) Sputumsmear positive case , miliary TB , moderately advance far advanced parenchymal involvement chest radiograph ( eligible cat I ) HIV positive Hepatitis B surface antigen ( HBsAg ) positive Diabetes mellitus Refusing thoracocentesis Evidence empyema Residence outside study area Refuse give consent</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Tuberculosis</keyword>
	<keyword>Pleural effusion</keyword>
	<keyword>Category 3</keyword>
</DOC>